Phreesia (PHR) has a profit margin of -1.98%, below the Healthcare sector average of 15.58%.
Get informed when a big investor buys or sells
+ FollowAs of Apr 2026
Trailing 12 months ending Apr 2026
The latest profit margin for PHR is -1.98% as of April 2026. That compares with -9.83% in the prior-year period — up 79.9% year over year. That is below the Healthcare sector average of 15.58%. Investors often review this figure alongside Phreesia's historical trend and sector peers before judging valuation or financial health.
Over the past year, PHR's profit margin moved from -9.83% to -1.98% — a 79.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Phreesia's valuation or profitability profile.
Against Healthcare companies, PHR currently prints -1.98% for profit margin, while the sector average sits near 15.58%. That is roughly 112.7% below the sector mean. Large gaps often invite a closer look at Phreesia's growth, margins, and balance sheet.
Profit Margin shows how effectively Phreesia converts resources into returns. At -1.98%, PHR may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -9.83% in the prior-year period — up 79.9% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting PHR's profit margin (-1.98%), review year-over-year change from -9.83%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.